UroGen Pharma Ltd (NASDAQ: URGN) shares are surging after the company released topline data from its Phase 3 trials ATLAS and ENVISION studying UGN-102 (mitomycin) for intravesical solution in patients with low-grade, intermediate-risk non-muscle invasive
Under the amended agreement, iRobot to be acquired for $51.75 per share in cash
iRobot is entering into new $200 million financing facility to fund its ongoing operations
Today Amazon (NASDAQ:AMZN)
Expands Board with New Highly Accomplished Independent Director
Strengthens Balance Sheet and Implements $15 Million Cost Reduction Initiative
BUFFALO, N.Y., July 24, 2023 (GLOBE NEWSWIRE) -- 22nd
A newly published study shows that Kernel’s Flow technology system is in fact able to capture and analyze brain changes following the administration of a psychoactive substance.
RedHill Biopharma Ltd (NASDAQ: RDHL) shares are down after the company announced a registered direct offering of 1.3 million American Depositary Shares, each ADS representing four hundred (400) ordinary shares, at a purchase price of $1.35 per ADS (or ADS equivalent), in a